Reynolds (NASDAQ:REYN) posts better-than-expected sales in Q3 2026
Reynolds (REYN) reported Q3 2026 revenue of $944M, beating estimates by 1%. Adjusted EPS met expectations at $0.39. Q4 revenue guidance of $1.03B is below estimates. Operating margin declined to 10.4% from 13.2% YoY. Free cash flow margin also decreased to 1%.
How this was made

The 30-second read
Why it matters
Earnings release provides fresh data; guidance miss may lead to short-term price pressure.
Market read
Primary earnings disclosure for a listed company; new numbers and guidance affect trading decisions.
What to watch
Operating margin contraction and free cash flow decline may be more material than the modest revenue miss.
Background
Reynolds (NASDAQ:REYN) reported Q3 2026 results with revenue slightly above estimates but guidance below consensus.
Ticker impact
Q3 2026 earnings beat revenue estimate and provided guidance below consensus.
likely modest downside as investors price in lower Q4 revenue guidance
Revenue beat is positive, but guidance below expectations typically triggers sell pressure.
Market effects
May affect other specialty chemicals peers as guidance miss signals broader demand concerns.
Limited to U.S. specialty chemicals sector.
Low
Counterpoint
The revenue beat could outweigh guidance miss if investors focus on top-line strength.
Key entities
- CompanyReynolds
Specialty chemicals manufacturer reporting Q3 2026 earnings.



